Arlene Morris - 03 Jan 2023 Form 4 Insider Report for VIVEVE MEDICAL, INC. (VIVE)

Role
Director
Signature
/s/ Jim Robbins, as Attorney-in-Fact
Issuer symbol
VIVE
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 15:03:02 UTC
Previous filing
24 Jun 2022
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIVE Restricted Stock Unit Award $0 +36,000 $0.000000 36,000 03 Jan 2023 Common Stock 36,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's common stock.
F2 The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer.